Abstract
Objectives
To assess the daily consumption of grass pea quantity, adverse effects if any, nutrition status among daily consumers and occurrence of morbidities.
Methods
For this purpose, a community based cross-sectional study was carried out in three districts (Bilaspur, Durg and Raipur) of Chhattisgarh state, India. Fifteen hundred households (HHs) per district, with 500HHs in each category (cultivators, non-cultivators, agriculture labourers and others labourers) as well as 400HHs were selected from 20 wards of the urban areas. Total of 360 split grass pea (SGP) samples were collected for β-ODAP analysis. Clinical examination was carried out in 17,755 individuals of all ages. Diet survey was done on 5769 HHs by 24 h recall method and by food frequency questionnaire (FFQ). Based on FFQ, HHs were separated into daily consumers of SGP and its quantity consumed and HHs that never consumed as non-consumers.
Results
Results of the study showed that there were 30 daily consuming and 89 non-consumer HHs, in all the three districts. Daily SGP consumers consumed at an average of 64 g/Cu/day SGP along with cereals & millets, and other vegetables in significantly higher quantities as compared to never SGP consumers. The average β-ODAP content in SGP was 0.630 g%. Morbidities such as hypertension, type 2 diabetes, stroke and bone fractures, among two groups of population was not significantly different, though tended to be low among daily consumers of SGP.
Conclusions
Results of the study showed that there were 30 daily consuming and 89 non-consumer HHs, in all the three districts. Daily SGP consumers consumed at an average of 64 g/Cu/day SGP along with cereals & millets, and other vegetables in significantly higher quantities as compared to never SGP consumers. The average β-ODAP content in SGP was 0.630 g%. Morbidities such as hypertension, type 2 diabetes, stroke and bone fractures, among two groups of population was not significantly different, though tended to be low among daily consumers of SGP. In
Funding Sources
India council of Medical Research, New Delhi.